LSX World Congress Annual Conference 2020 | LSX - The Network For Life Science Executives | 4 February 2020 | etc.venues 133 Houndsditch, Liverpool St, London EC3A 7BX, UK

For 5 years, the LSX World Congress has been bringing together the executives that matter to the future of healthcare and life science business strategy, investment, partnering, deal making and commercialisation.

LSX World Congress gathers the founders and CEOs of innovative start-ups through to publicly listed life science giants, and everyone in between. It represents the breadth and depth of the cutting-edge research and technology driving the advances in the industry right now and in the near future.

The industry’s c-suite will be joined by the sector’s most active investors, pharma and healthtech BD&L teams, key stakeholders and top tier service companies who are moving the sector forward.

In an industry as dynamic as the life science and healthcare sector, LSX World Congress brings the people who are tackling the biggest challenges in the industry today, and helps answer the question; where to next and how do we get there?

With our relentless focus on quality peer-to-peer discussion, high-level networking and partnering, unique conference formats and a vetted, high-calibre audience, we help you Connect with purpose™.

2020 Speakers

Saif Abed
Founding Partner, AbedGraham, Cyber Security Expert, European Commission and WHO

Robert Abbott
Vice President, Chief Legal Counsel EMEA, Stryker

Hani Abouhalka
Company Group Chairman - Medical Devices EMEA, Johnson & Johnson

Marcello Agosti
Global Business Development Officer, Takeda

Renée Aguiar-Lucander
CEO, Calliditas

Shafi Ahmed
CMO, Medical Realities

Ingrid Akay
Managing Partner, Hadean Ventures

Maarten Akkerman
VP Medical Affairs & Value-Based Healthcare EMEA, Medtronic

Sascha Alilovic
Partner, SHS Capital

Mark Altmeyer
CEO, Arvelle Therapeutics

Michael Altorfer
CEO, SwissBiotech

Derk Arts
CEO, Castor

Steve Atkinson
CEO, Atlantic Healthcare

Frances Ayalasomayajula
Head of Population Health, HP

Caroline Barelle
CEO, Elasmogen

Assaf Barnea
CEO, Sanara Ventures

Pierre Belichard
CEO, Enterome Bioscience

Gregory Benning
MD & Group Head M&A, Back Bay Life Science Advisors

Xavier Bertrand
Vice President Healthcare Services and Alliances EMEA, Boston Scientific

Alessio Beverina
Managing Partner, Panakes Partners

Maina Bhaman
Partner, Sofinnova

Peter Bisgaard
Managing Director, Nan Fung Life Sciences

Jeanne Bolger
Vice President, Venture Investments, Johnson & Johnson Innovation

Elena Bonfiglioli
MD Health Industry EMEA, Microsoft

Eduardo Bravo
CEO, Nordic Nanovector

Søren Bregenholt
CEO, Macrophage

Paul Brown
Chief Financial Officer, North West London CCGs, NHS England

Seamus Browne
Head of Industry Partnerships, Royal College of Surgeons

Roel Bulthuis
Managing Director, Inkef Capital

Sergio Capancioni
Director Search & Evaluation Western Europe, AbbVie

Lifei Cheng
Founder & CEO, MedTecx

Katherine Cohen
Venture Partner, Panacea Ventures

Stuart Collinson
CEO, Oxstem

Edward Cox
CEO, Dthera Sciences

Adelaide Cracco
Head of Life Sciences, European Investment Fund

Laia Crespo
Head of Europe, Sanofi Ventures

Ian Crosbie
CEO, Sequana Medical AG

Jane Dancer
CBO, F-Star

Nissim Darvish
Senior Managing Director, OrbiMed

John Dawson
CEO, Oxford BioMedica

Susana de Azevedo Wäsch
VP Quality Management & Regulatory Affairs, Ypsomed AG

Don deBethizy
Chair of Board, Saniona AB

Fiona de Hemptinne
Venture Partner, UCB Ventures

Rudy Dekeyser
Managing Partner, LSP Health Economics Fund

Richard di Benedetto
President, Aetna International

Luc Dochez
Managing Director, PrimixBioVentures

Joe Dupere
CEO, Rexgenero

Johnston Erwin
VP Corporate Business Development, Eli Lilly

Kristien Esser
CEO, Guided Solutions

Sarah Fisher
Senior Director, Global Markets, External Innovation, Johnson & Johnson

Mathias Flume
Head of Department, KVWL

Miriam Frieden
VP Search & Evaluation, Novo Nordisk

Martin Frost
CEO, CMR Surgical

Caroline Gaynor
Vice President, Lightstone Ventures

Manuela Gazzard
Group Executive Director, Regulatory Services Healthcare, BSI Group

David Germonpré
Investment Partner, MTIP

Jonathan Gertler
Managing Partner & CEO, Back Bay Life Science Advisors

Hakan Goker
Senior Investment Director, M Ventures

Jonathan Goldstein
Partner, Boston Scientific

Mathias Goyen
CMO Europe, GE Healthcare

Theo Harold
CEO, Crescendo Biologics

Ori Hadomi
CEO, Mazor Robotics

Mattias Haeggblom
Portfolio Manager, Swedbank Robur

Deborah Harland
Partner, SR One

Zishan Haroon
Chairman & General Partner, Julz Co LLC

Mark-Jan Harte
Co-Founder & CEO, Aidence

Olav Hellebo
CEO, ReNeuron Group

Jens Hennecke
CBO, Sotio AS

David Horn Solomon
CEO, Silence Therapeutics

Leon Hooftman
CMO, ISA Pharmaceuticals

Alice Hu Wagner
Managing Director, British Business Bank

Thomas Hummel
Head of Innovation & Strategy, Siemens Healthineers

Sofia Ioannidou
Partner, Andera Partners

Annalisa Jenkins
Chair to European biotechs

Arnd Kaltofen
General Partner, VI Partners

Edward Kliphuis
Investment Director, M Ventures

Adam Kostyal
SVP, Nasdaq

Charity Kufaas
VP BD, Medtronic

Phil L’Hullier
Head of BD, Europe, European Innovation Hub, MSD

Jacques Lafon
President Medical Segment, EMEA, Cardinal Health

Werner Lanthaler
CEO, Evotec

Kevin Lee
CEO, Bicycle Therapeutics

Søren Lemonius
Managing General Partner, Sunstone Life Science Ventures

Leon Lerman
CEO & Co-Founder, Cynerio

Karen Liu
Partner, 3E BioVentures

Thomas Lönngren
Former Head of EMA & Advisor, NDA

Philippe Lopes-Fernandes
SVP, Global Head of BD & Alliance Management, Merck KGaA

Tim Luker
Senior Director External Innovation, Eli Lilly

Frank Maddux
Global CMO, Fresenius Medical Care

Dave Madge
VP of the Research Service Division, WuXi AppTec

Ivana Magovčević-Liebisch
CBO, Ipsen

Anoop Maini
CEO, Excite Ventures

Sean Marett
CBO, CCO, BioNTech AG

Giovanni Mariggi
Partner, Medicxi

Craig Marshall
CEO, OrganOx

Ben Maruthappu
CEO, Cera

Giuseppe Mazza
CEO, Engitix

John E Milad
CEO, Quanta Dialysis

Edwin Moses
former CEO Ablynx and Chairman to European biotechs

Bibhash Mukhopadhyay
Principal, New Enterprise Associates

Sumit Nagpal
Founder & CEO, CareFully

Jordi Naval
CEO, Biocat

Jack Nielsen
MD, Vivo Capital

Mark O'Herlihy
MD EMEA, IBM Watson Health

Geraldine O’Keeffe
Partner Public Equities, LSP

Daniel O’Mahony
Partner, Seroba Life Sciences

Francis Pang
VP Global Market Access, Orchard Therapeutics

Anthony Pagano
SVP Finance & Corporate Development, Genmab

Martin Pfister
Senior Investment Manager, High-Tech Gründerfonds

Laura Piccinini
Global Head of Commercial Operations, Envista Holdings Corporation

Catherine Pickering
CEO, iOnctura

James Pink
Executive Vice President - Consulting, NSF Health Sciences

John Power
CEO, Aerogen

Ena Prosser
Partner, FH Partners

Vivek Ramaswamy
CEO, Roivant Sciences

Mike Romanos
CEO, Microbiotica

Kieran Rooney
VP Strategic Alliances and Licensing, Amryt Pharma

Bernard Ross
CEO & Founder, First Kind Medical

Thibaut Roulon
Investment Director - Life Sciences, Bpifrance

Christoph Ruedig
Partner, Albion Capital

Mirko Scherer
CEO, CoFeS China Ltd

Eliane Schutte
CEO, Xeltis

Denise Scots-Knight
CEO, Mereo Biopharma

Sara Secall
Investment Director & Partner, Inveready Asset Management

Graziano Seghezzi
Managing Partner, Sofinnova Partners

Sarah Shackleton
Partner, Marketing & Talent, Abingworth

Nigel Sheail
Global Head of M&A and BD&L, Novartis

Kyparissia Sirinakis
Managing Partner, Epidarex

Ulrica Slåne Bjerke
CIO, Arctic Aurora LifeScience

Yochi Slonim
Co-Founder & CEO, Anima Biotech Inc

Sander Slootweg
Managing Partner, Forbion

Patrik Sobocki
Investor, Industrifonden

Jens Stegemann
Former CEO, Breath Therapeutics

Carl Sterritt
CEO, Shield Therapeutics

Rainer Strohmenger
Managing Partner, Wellington Partners

Steve Swinson
Chair, Comphya and Tibbyah Holdings, Former Chair, Acteon, Vexim, Bone Therapeutics

Chas Taylor
CEO & Executive Director, Veryan Medical

Rafaèle Tordjman
Founder & CEO, Jeito

Luella Trickett
Director Value and Access, Association of British HealthTech Industries

David Tuch
CEO, Lightpoint Medical

Peter Ullrich
CEO, Titan Spine

Todd Usen
CEO, Activ Surgical

Onno Van de Stolpe
CEO, Galapagos

Erik van den Berg
CEO, AM-Pharma

Vanessa Vankerckhoven
CEO & Co-Founder, Novosanis NV

Montserrat Vendrell
General Partner, Alta Life Sciences

Cedric Ververken
CEO, Confo Therapeutics

Guillaume Vignon
SVP Business Development, BeiGene

Eline Vrijland-Van Beest
Partner, Blue Sparrows MedTech Fund

Jason Ward
Group Director, AstraZeneca

Ian Wilson
CEO, ImaginAb

Rupert Winckler
Head of EMEA Business Development, Olympus

Marietta Wu
Managing Director, Quan Capital

Andreas Wuepper
Partner, Fresenius Medical Care

Donald Xu
Managing Partner, Lynx Financial

Frank Yu
CEO, Ally Bridge Group

Dan Zhang
Executive Chairman, Fountain Medical Development

Constantinos Ziogas
Head of SME Office, European Medicines Agency

Lars van der Veen
COO, iOnctura

2020 Partners

PLATINUM PARTNERS:
• Nasdaq
• Goldman Sachs
• Eli Lilly
• Medtronic

GOLD PARTNERS:
• Back Bay Life Science Advisors
• Bird & Bird
• Citi
• CMS
• Covington
• Donnelley Financial Solutions (DFIN)
• Goodwin
• Guided Solutions
• Latham and Watkins
• MSD
• NDA Group
• Novo Nordisk
• Premier Research
• SVB Leerink
• White & Case

SILVER PARTNERS:
• Kempen
• Wuxi Apptec

EXHIBITOR:
• Confluence Tax

SUPPORTING PARTNERS:
• Biocat
• Citigate Dewe Rogerson
• Consilium Strategic Communications
• Edison Investment Research
• FreeMind
• Instinctif
• Medicon Valley Alliance
• Optimum Strategic Communications
• Sciad
• Zyme Communications

MEDIA PARTNERS:
• Pharma Tech Outlook
• PharmaVoice